Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-<i>β</i>1/Smad3 and TGF-<i>β</i>1/p38 MAPK Pathways

Ning Liu(Tongji University), Yingqun Zhou(Tongji University)
Mediators of Inflammation
July 31, 2019
Cited by 120


Related Papers